Neuroone Medical Technologies (NMTC) Shares Outstanding (Diluted Average) (2011 - 2026)

Neuroone Medical Technologies has disclosed Shares Outstanding (Diluted Average) across 7 years of filings, most recently posting $8.5 million for Q1 2026.

• Quarterly Shares Outstanding (Diluted Average) rose 63.64% year-over-year to $8.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.5 million (up 63.64% YoY) and the FY2025 annual result came in at $40.2 million, up 50.03% from the prior year.
• Shares Outstanding (Diluted Average) declined to $8.5 million in Q1 2026, from $50.3 million in the prior quarter.
• Across five years, Shares Outstanding (Diluted Average) topped out at $50.3 million in Q4 2025 and bottomed at $5.2 million in Q1 2025.
• The 5-year median for Shares Outstanding (Diluted Average) is $18.1 million (2023), against an average of $22.9 million.
• Year-over-year, Shares Outstanding (Diluted Average) jumped 67.68% in 2022 and plunged 79.22% in 2025.
• Neuroone Medical Technologies' Shares Outstanding (Diluted Average) stood at $16.2 million in 2022, then surged by 47.84% to $24.0 million in 2023, then increased by 28.69% to $30.9 million in 2024, then surged by 62.99% to $50.3 million in 2025, then tumbled by 83.14% to $8.5 million in 2026.
• According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods registered $8.5 million, $50.3 million, and $40.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.